OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
Tejas Patil, Alyse Staley, Yunan Nie, et al.
JTO Clinical and Research Reports (2024) Vol. 5, Iss. 2, pp. 100637-100637
Open Access | Times Cited: 5
Tejas Patil, Alyse Staley, Yunan Nie, et al.
JTO Clinical and Research Reports (2024) Vol. 5, Iss. 2, pp. 100637-100637
Open Access | Times Cited: 5
Showing 5 citing articles:
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
Yi‐Long Wu, Valentina Guarneri, Pei Jye Voon, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. 989-1002
Closed Access | Times Cited: 17
Yi‐Long Wu, Valentina Guarneri, Pei Jye Voon, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. 989-1002
Closed Access | Times Cited: 17
Case report: Aumolertinib plus gumarontinib in a patient with EGFR mutated non-small-cell lung cancer harboring acquired MET amplification following progression on afatinib plus crizotinib
Jia-Jun Hui, Shan Ding, Bao‐Dong Qin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Jia-Jun Hui, Shan Ding, Bao‐Dong Qin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer
Martin Sattler, Ravi Salgia
Cell Reports Medicine (2025), pp. 101983-101983
Open Access
Martin Sattler, Ravi Salgia
Cell Reports Medicine (2025), pp. 101983-101983
Open Access
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration
Huijing Feng, Yang Xia, Wenxian Wang, et al.
Cancer Biology and Medicine (2025), pp. 237-265
Open Access
Huijing Feng, Yang Xia, Wenxian Wang, et al.
Cancer Biology and Medicine (2025), pp. 237-265
Open Access
The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations
Tejas Patil, Dexiang Gao, Alexander Watson, et al.
Lung Cancer (2024) Vol. 199, pp. 108040-108040
Closed Access | Times Cited: 1
Tejas Patil, Dexiang Gao, Alexander Watson, et al.
Lung Cancer (2024) Vol. 199, pp. 108040-108040
Closed Access | Times Cited: 1
